US › Healthcare

Trevena Inc (TRVN)

US · Healthcare · Biotechnology

$0.010.00%

Last close · 2026-08-04

Latest quarter · ended 2024-09-30

Revenue

$283,000

Revenue YoY

+57.2%

Net profit

$-4.9M

Profit YoY

+37.7%

EPS

$-5.79

EPS estimate

$-7.75

Net margin

-1,745.2%

EPS came in at -5.79 against a street estimate of -7.75 — a beat of 25.3%.

Key statistics

Market cap

$9,501

Forward P/E

0.0

P/B

0.36

Book value

$-27.27

EPS (TTM)

$-48.89

52-week high

$0.28

52-week low

$0.00

50-day MA

$0.01

200-day MA

$0.01

Beta

0.17

Analyst view

Analysts rate Trevena Inc a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $5.00.

Shareholding

Insiders

0.48%

Largest institutional holders

Fund	Stake
Advisor Group Holdings, Inc.	0.00%
Activest Wealth Management	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Trevena Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.